Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Other Operating Expenses (2019 - 2025)

Volitionrx's Other Operating Expenses history spans 9 years, with the latest figure at $1499.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 4044.74% year-over-year to $1499.0; the TTM value through Dec 2025 reached $919128.0, down 43.89%, while the annual FY2025 figure was $1829.0, 105.27% up from the prior year.
  • Other Operating Expenses reached $1499.0 in Q4 2025 per VNRX's latest filing, up from $330.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1.8 million in Q4 2021 to a low of -$33498.0 in Q2 2024.
  • Average Other Operating Expenses over 5 years is $705465.4, with a median of $494657.0 recorded in 2021.
  • Peak YoY movement for Other Operating Expenses: plummeted 154.29% in 2024, then skyrocketed 4044.74% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $1.8 million in 2021, then dropped by 3.57% to $1.8 million in 2022, then tumbled by 100.0% to $70.0 in 2023, then tumbled by 154.29% to -$38.0 in 2024, then surged by 4044.74% to $1499.0 in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Other Operating Expenses are $1499.0 (Q4 2025), $330.0 (Q2 2025), and $917299.0 (Q1 2025).